智通财经APP获悉，微创心通-B(02160)盘中涨超9%，截至发稿，涨6.06%，报1.05港元，成交额448.37万港元。
消息面上，微创心通的VitaFlow Liberty/自由·维心流经导管主动脉瓣及可回收系统，摩洛哥获批上市，标志着该产品首次进入非洲市场。摩洛哥医疗器械市场对进口产品依赖度高，此次获批为该产品后续拓展非洲其他国家奠定基础。
值得注意的是，12月19日，微创医疗宣布心通收购心律的合并落地。此次并购将推动微创医疗旗下结构性心脏病与心律管理两大核心业务板块的深度整合。随着最新整合方案的公布，意味着微创医疗将加速构建覆盖心力衰竭全病因、全阶段、全过程的综合器械管理方案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.